← Back to Search

Other

MC-1101 active for Age-Related Macular Degeneration (McCP2/3 Trial)

Phase 2 & 3
Waitlist Available
Led By Mitchell J Goff, MD
Research Sponsored by MacuCLEAR, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 months

Summary

This trial is testing eye drops called MC-1101 on patients with a specific type of age-related vision problem. The goal is to see if these drops can improve blood flow in the eye and help with their condition.

Eligible Conditions
  • Age-Related Macular Degeneration

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Visual Function
Secondary study objectives
Safety and tolerability (incidence and severity of adverse events, ocular irritability, ocular hyperemia)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: MC-1101 activeExperimental Treatment1 Intervention
Topical Drug 1% Ophthalmic Solution Topically, two times per day; morning and bedtime
Group II: MC-1101 Vehicle ControlPlacebo Group1 Intervention
Topical Drug: Ophthalmic Solution Topically, two times per day; morning and bedtime
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MC-1101
2009
Completed Phase 1
~40

Find a Location

Who is running the clinical trial?

MacuCLEAR, Inc.Lead Sponsor
3 Previous Clinical Trials
73 Total Patients Enrolled
Mitchell J Goff, MDPrincipal InvestigatorRocky Mountain Retina Consultants
~5 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top